IPOs

IPOs 2023

Biotech IPOs in 2023, their targets, platforms, indications and lead-candidate stage.

IPOs 2022

Biotech IPOs in 2022, their targets, platforms, indications and lead-candidate stage.

IPOs 2021

Biotech IPOs in 2021, their targets, platforms, indications and lead-candidate stage.

Pipelines

DEB

Dystrophic epidermolysis bullosa approved therapies and global pipeline database.

DMD

Duchenne muscular dystrophy oligonucleotide and gene therapy global pipeline database.

DM1 & DM2

Myotonic dystrophy global pipeline database. Full company list, candidates, targets, stage & clinical trials.

HAE

Hereditary angioedema approved therapies & global pipeline database.

LGMD

Limb-girdle muscular dystrophy gene therapy database. Companies, candidates & mechanisms.

MCL-1

Drug development landscape for MCL-1 inhibitors.

PRMT5

Drug development landscape for PRMT5 inhibitors.

RAS, SOS1, SHP2

Drug development landscape for RAS, SOS1 and SHP2 inhibitors/degraders.

SCD

Sickle cell disease approved therapies, global pipeline and Oxbryta sales data.

SMA

Spinal muscular atrophy global pipeline and market (net product sales of Spinraza, Evrysdi & Zolgensma).

TPD

Targeted protein degradation global pipeline database. Full list of companies, candidates & targets.

UM

Uveal melanoma global pipeline and market (net product sales of KIMMTRAK).

wAMD

Wet age-related macular degeneration global pipeline and approved therapies.